A winning strategy is essential to reach or accomplish goals in pharmaceutical industry. However, maintaining the excellence of Strategic Drug Development Services is a necessary stipulation for the Strategic evolution for Pharma companies. The technologies leading to Pharmaceutical regulatory strategy and Pharmaceutical strategic developments are at the limits of human knowledge. The huge size of the companies, organizations and the complexities of their technologies and processes present many challenges. On the other hand, strategy development and distribution system is highly costly to implement. The effective Pharma strategies can help to generate business exposure, relationship building, and market research. Thus, they are important initiatives to boom overall business in the long term.

Globalisation

The right steps to successfully break into a new market

As the pharmaceutical industry squares off against the challenge of globalisation there is a greater need for content than ever Driven by forces from both the clinical and commercial sides pharmaceutical companies are experiencing rising costs and competition Ultimately to enable businesses to compe..

Life Story

The idea of product life cycle is more useful that you realise

The idea of Product Life Cycle PLC is familiar to any experienced executive in pharma or medtech Its often assumed to be synonymous with line extension tactics such as reformulation or label extension that can be used to defend against metoos and generics But the inventors of the concept meant PLC t..

China Biopharma

Is a Wave of GMP Exports in Our Future?

China today according to our recent studies is actively growing its domestic industry not only to support its huge domestic demand for high quality therapeutics but also to develop an export market capability The industry is making progress with substantial investments in equipment quality manageme..

Failing Data Integrity Audit is not an Option

The timetomarket of blooming Asian pharmaceutical companies especially from India and China are being slowed by the increasing concerns of global and local regulators over data integrity How can they meet regulators audit expectation on data integrity and provide assurance of acceptable product qual..

Indian Pharma Companies Need Supply Chain Transformation

Unlocking growth

Indias pharmaceutical companies have a unique opportunity to lead global growth for years to come However there is a significant gap between the strategic vision and operational realities of the sector Firms are facing challenges on multiple fronts in their supply chains They need to overcome these ..

Generics in Switzerland

The portrait

The article talks about the Swiss Generics market the penetration rate of generics in Switzerland why generics are a safe and smarter choice manufactured to modern standards with affordable prices and the threat of government forcing generic companies to benchmark their prices to nine European count..

Plotting Efficient Paths for Clinical Development

Clinical development is a complex puzzle with elements such as geography regulatory requirements epidemiology technology and expertise all contributing to successfully bringing a product to market Development of TLC388 in Asia for the treatment of liver cancer illustrates geographic advantages in ac..

Trends in Pharma Export Industry in India

The Indian pharmaceuticals market has become the largest exporter of medicines by volume India is the largest provider of generic drugs globally with the Indian generics accounting for 20 per cent of global exports in terms of volume In terms of market size the Indian pharma industry which is expect..

Four Switches of Success

Very similar firms often achieve very different results This is explained by their genetic switches..

The Future of Pharma Regulations

The future of pharma regulations is challenging with diverse and complex regulations globally It will be challenging for industry to adapt to regulated and semiregulated markets alike while attempting to develop a harmonised strategy with evergrowing cost pressure on offpatent products for both smal..